𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety and immunogenicity of an inactivated hepatitis A vaccine in children 2 to 5 years old

✍ Scribed by J. Arístegui; E. Garrote; J. L. Morales; Maria S. Gallego; R. Dal-Ré; A. González

Publisher
Springer-Verlag
Year
1995
Tongue
English
Weight
861 KB
Volume
23
Category
Article
ISSN
0300-8126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and safety of a new inact
Immunogenicity and safety of a new inactivated hepatitis a vaccine in a comparative study
✍ Dr. Christian Goilav; Jane Zuckerman; Michael Lafrenz; Emmanuel Vidor; Sabine La 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 668 KB

## Abstract A multicentre, controlled, randomised, open, comparative trial including 839 healthy adult volunteers was carried out in order to compare the immunogenicity and reactogenicity of two vaccines against hepatitis A virus (HAV) during primary immunization and after booster injection. The fi

Safety and immunogenicity of inactivated
Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease
✍ Lee, Shou-Dong; Chan, Cho-Yu; Yu, May-Ing; Wang, Yuan-Jen; Chang, Full-Young; Lo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 2 views

The safety and immunogenicity of inactivated hepatitis A vaccine was evaluated in patients with chronic liver disease. Sixty hepatitis A virus antibody (anti-HAV) seronegative patients with chronic liver disease (56 chronic hepatitis B and four chronic hepatitis C) and from 17 to 47 years of age rec

Immunogenicity and safety of an inactiva
Immunogenicity and safety of an inactivated hepatitis a vaccine in anti-HIV positive and negative homosexual men
✍ Dr. Georg Hess; Ralf Clemens; Ulrich Bienzle; Christian Schönfeld; Birgit Schunc 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

The immunogenicity, reactogenicity, and safety of an inactivated hepatitis A vaccine were assessed in anti-HIV positive homosexual men. Fourteen anti-HIV positive (group 1) and 20 anti-HIV negative (group 2) men received vaccine (containing 720 ELISA units of hepatitis A antigen per dose) intramuscu